Patent · US Active

Polynucleotides encoding human oncostatin M antibodies

US9587018B2 · kind B2 · utility

0Cited by
23References
21Claims
0Family size

Inventors

Key dates

Filing dateSep 30, 2015
Grant dateMar 7, 2017
Priority date
Expiry dateSep 30, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/94
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Antibodies and compositions capable of neutralizing oncostatin M biological functions are useful in treating diseases and disorders associated with oncostatin M, such as osteoarthritis and idiopathic pulmonary fibrosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.